1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Proteomics Market
2.2. Global Proteomics Market, By Component, 2023 (US$ Million)
2.3. Global Proteomics Market, By Application, 2023 (US$ Million)
2.4. Global Proteomics Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023
3. Proteomics Market: Competitive Analysis
3.1. Market Positioning of Key Proteomics Market Vendors
3.2. Strategies Adopted by Proteomics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Proteomics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Proteomics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Proteomics Market: By Component, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Instrumentation Technology
5.3.1.1. Protein Microarrays
5.3.1.1.1. Biochips
5.3.1.1.2. Microarray Instruments
5.3.1.2. Spectroscopy
5.3.1.3. ELISA
5.3.1.4. X-Ray Crystallography
5.3.1.5. Chromatography
5.3.1.5.1. HPLC
5.3.1.5.2. Ion Chromatography
5.3.1.5.3. Others (Affinity Chromatography & Supercritical Fluid Chromatography)
5.3.1.6. Electrophoresis
5.3.1.7. Others (Surface Plasmon Resonance, Western Blotting, & Protein Fractionation Systems)
5.3.2. Consumables and Reagents
5.3.2.1. Protein Microarray Consumables and Reagents
5.3.2.2. Spectroscopy Consumables and Reagents
5.3.2.3. X-Ray Crystallography Consumables and Reagents
5.3.2.4. Chromatography Consumables and Reagents
5.3.2.5. Electrophoresis Consumables and Reagents
5.3.2.6. Immunoassay Consumables and Reagents
5.3.2.7. Protein Fractionation Consumables and Reagents
5.3.3. Services
5.3.3.1. Analytical Laboratory Services
5.3.3.2. Data Analysis & Maintenance
5.3.3.3. Quantification Services
6. Proteomics Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Drug Discovery
6.3.2. Clinical Diagnostics
7. North America Proteomics Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Proteomics Market: By Component, 2022-2032, USD (Million)
7.3. Proteomics Market: By Application, 2022-2032, USD (Million)
7.4.Proteomics Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Proteomics Market: By Component, 2022-2032, USD (Million)
7.4.1.1.2. Proteomics Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Proteomics Market: By Component, 2022-2032, USD (Million)
7.4.1.2.2. Proteomics Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Proteomics Market: By Component, 2022-2032, USD (Million)
7.4.1.3.2. Proteomics Market: By Application, 2022-2032, USD (Million)
8. UK and European Union Proteomics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Proteomics Market: By Component, 2022-2032, USD (Million)
8.3. Proteomics Market: By Application, 2022-2032, USD (Million)
8.4.Proteomics Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Proteomics Market: By Component, 2022-2032, USD (Million)
8.4.1.1.2. Proteomics Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Proteomics Market: By Component, 2022-2032, USD (Million)
8.4.1.2.2. Proteomics Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Proteomics Market: By Component, 2022-2032, USD (Million)
8.4.1.3.2. Proteomics Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Proteomics Market: By Component, 2022-2032, USD (Million)
8.4.1.4.2. Proteomics Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Proteomics Market: By Component, 2022-2032, USD (Million)
8.4.1.5.2. Proteomics Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Proteomics Market: By Component, 2022-2032, USD (Million)
8.4.1.6.2. Proteomics Market: By Application, 2022-2032, USD (Million)
9. Asia Pacific Proteomics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Proteomics Market: By Component, 2022-2032, USD (Million)
9.3. Proteomics Market: By Application, 2022-2032, USD (Million)
9.4.Proteomics Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Proteomics Market: By Component, 2022-2032, USD (Million)
9.4.1.1.2. Proteomics Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Proteomics Market: By Component, 2022-2032, USD (Million)
9.4.1.2.2. Proteomics Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Proteomics Market: By Component, 2022-2032, USD (Million)
9.4.1.3.2. Proteomics Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Proteomics Market: By Component, 2022-2032, USD (Million)
9.4.1.4.2. Proteomics Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Proteomics Market: By Component, 2022-2032, USD (Million)
9.4.1.5.2. Proteomics Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Proteomics Market: By Component, 2022-2032, USD (Million)
9.4.1.6.2. Proteomics Market: By Application, 2022-2032, USD (Million)
10. Latin America Proteomics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Proteomics Market: By Component, 2022-2032, USD (Million)
10.3. Proteomics Market: By Application, 2022-2032, USD (Million)
10.4.Proteomics Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Proteomics Market: By Component, 2022-2032, USD (Million)
10.4.1.1.2. Proteomics Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Proteomics Market: By Component, 2022-2032, USD (Million)
10.4.1.2.2. Proteomics Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Proteomics Market: By Component, 2022-2032, USD (Million)
10.4.1.3.2. Proteomics Market: By Application, 2022-2032, USD (Million)
11. Middle East and Africa Proteomics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Proteomics Market: By Component, 2022-2032, USD (Million)
11.3. Proteomics Market: By Application, 2022-2032, USD (Million)
11.4.Proteomics Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Proteomics Market: By Component, 2022-2032, USD (Million)
11.4.1.1.2. Proteomics Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Proteomics Market: By Component, 2022-2032, USD (Million)
11.4.1.2.2. Proteomics Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Proteomics Market: By Component, 2022-2032, USD (Million)
11.4.1.3.2. Proteomics Market: By Application, 2022-2032, USD (Million)
12. Company Profile
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Agilent Technologies, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Bio-Rad Laboratories, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Merck KGaA
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Danaher Corporation
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Luminex Corporation
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Perkin Elmer, Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Waters Corporation
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. GE Healthcare
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Bruker Corporation
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Caprion Proteomics Inc.
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Shimadzu Biotech
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
